Proceeds Support Advancement of the M-gager Platform Technology and Lead Product Candidate CDR404, a First Antibody Fragment-based Dual MAGE-A4 T Cell Engager, and Other Discovery ProgramsZÜRICH, Switzerland
CDR-Life is a Swiss Biotech company at the forefront of a new class of highly tumor-specific immuno-oncology therapeutics. CDR-Life leverages the unique expertise and track record of its founders